Literature DB >> 27573245

Human DNA Ligase I Interacts with and Is Targeted for Degradation by the DCAF7 Specificity Factor of the Cul4-DDB1 Ubiquitin Ligase Complex.

Zhimin Peng1, Zhongping Liao2, Yoshihiro Matsumoto1, Austin Yang2, Alan E Tomkinson3.   

Abstract

The synthesis, processing, and joining of Okazaki fragments during DNA replication is complex, requiring the sequential action of a large number of proteins. Proliferating cell nuclear antigen, a DNA sliding clamp, interacts with and coordinates the activity of several DNA replication proteins, including the enzymes flap endonuclease 1 (FEN-1) and DNA ligase I that complete the processing and joining of Okazaki fragments, respectively. Although it is evident that maintaining the appropriate relative stoichiometry of FEN-1 and DNA ligase I, which compete for binding to proliferating cell nuclear antigen, is critical to prevent genomic instability, little is known about how the steady state levels of DNA replication proteins are regulated, in particular the proteolytic mechanisms involved in their turnover. Because DNA ligase I has been reported to be ubiquitylated, we used a proteomic approach to map ubiquitylation sites and screen for DNA ligase I-associated E3 ubiquitin ligases. We identified three ubiquitylated lysine residues and showed that DNA ligase I interacts with and is targeted for ubiquitylation by DCAF7, a specificity factor for the Cul4-DDB1 complex. Notably, knockdown of DCAF7 reduced the degradation of DNA ligase I in response to inhibition of proliferation and replacement of ubiquitylated lysine residues reduced the in vitro ubiquitylation of DNA ligase I by Cul4-DDB1 and DCAF7. In contrast, a different E3 ubiquitin ligase regulates FEN-1 turnover. Thus, although the expression of many of the genes encoding DNA replication proteins is coordinately regulated, our studies reveal that different mechanisms are involved in the turnover of these proteins.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DNA ligase I; DNA replication; cell cycle; proliferating cell nuclear antigen (PCNA); proteasome; protein turnover; proteolysis; ubiquitin; ubiquitin ligase; ubiquitylation

Mesh:

Substances:

Year:  2016        PMID: 27573245      PMCID: PMC5063974          DOI: 10.1074/jbc.M116.746198

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Growth retardation and immunodeficiency in a patient with mutations in the DNA ligase I gene.

Authors:  A D Webster; D E Barnes; C F Arlett; A R Lehmann; T Lindahl
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

2.  CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome.

Authors:  Regina Groisman; Isao Kuraoka; Odile Chevallier; Nogaye Gaye; Thierry Magnaldo; Kiyoji Tanaka; Alexei F Kisselev; Annick Harel-Bellan; Yoshihiro Nakatani
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

3.  A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

Authors:  Jianping Jin; Emily E Arias; Jing Chen; J Wade Harper; Johannes C Walter
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

4.  Elevated expression of DNA ligase I in human cancers.

Authors:  D Sun; R Urrabaz; M Nguyen; J Marty; S Stringer; E Cruz; L Medina-Gundrum; S Weitman
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

5.  REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase.

Authors:  Samiksha Katiyar; Enbo Liu; Christine A Knutzen; Elizabeth S Lang; Christian R Lombardo; Sabita Sankar; Julia I Toth; Matthew D Petroski; Ze'ev Ronai; Gary G Chiang
Journal:  EMBO Rep       Date:  2009-06-26       Impact factor: 8.807

6.  Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome.

Authors:  Jacek R Wiśniewski; Alexandre Zougman; Matthias Mann
Journal:  J Proteome Res       Date:  2009-12       Impact factor: 4.466

Review 7.  The DNA replication fork in eukaryotic cells.

Authors:  S Waga; B Stillman
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

8.  Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents.

Authors:  D E Barnes; A E Tomkinson; A R Lehmann; A D Webster; T Lindahl
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

9.  Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene.

Authors:  Caroline Harrison; Ann-Marie Ketchen; Nicola J Redhead; Maureen J O'Sullivan; David W Melton
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

10.  DNA ligase I is recruited to sites of DNA replication by an interaction with proliferating cell nuclear antigen: identification of a common targeting mechanism for the assembly of replication factories.

Authors:  A Montecucco; R Rossi; D S Levin; R Gary; M S Park; T A Motycka; G Ciarrocchi; A Villa; G Biamonti; A E Tomkinson
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

View more
  10 in total

1.  DCAF7 is required for maintaining the cellular levels of ERCC1-XPF and nucleotide excision repair.

Authors:  Hiroaki Kawara; Ryo Akahori; Mitsuo Wakasugi; Aziz Sancar; Tsukasa Matsunaga
Journal:  Biochem Biophys Res Commun       Date:  2019-09-04       Impact factor: 3.575

2.  Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor.

Authors:  Timothy R L Howes; Annahita Sallmyr; Rhys Brooks; George E Greco; Darin E Jones; Yoshihiro Matsumoto; Alan E Tomkinson
Journal:  DNA Repair (Amst)       Date:  2017-10-10

Review 3.  Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.

Authors:  Sang-Min Jang; Christophe E Redon; Mirit I Aladjem
Journal:  Front Mol Biosci       Date:  2018-03-13

4.  DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B.

Authors:  Mina Yousefelahiyeh; Jingyi Xu; Estibaliz Alvarado; Yang Yu; David Salven; Robert M Nissen
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

5.  DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169.

Authors:  Vijay R Menon; Varsha Ananthapadmanabhan; Selene Swanson; Siddharth Saini; Fatmata Sesay; Vasily Yakovlev; Laurence Florens; James A DeCaprio; Michael P Washburn; Mikhail Dozmorov; Larisa Litovchick
Journal:  Cell Cycle       Date:  2019-02-17       Impact factor: 4.534

Review 6.  Revisiting the Function of p21CDKN1A in DNA Repair: The Influence of Protein Interactions and Stability.

Authors:  Giulio Ticli; Ornella Cazzalini; Lucia A Stivala; Ennio Prosperi
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

7.  DCAF7 regulates cell proliferation through IRS1-FOXO1 signaling.

Authors:  Scott Frendo-Cumbo; Taoyingnan Li; Dustin A Ammendolia; Etienne Coyaud; Estelle M N Laurent; Yuan Liu; Philip J Bilan; Gordon Polevoy; Brian Raught; Julie A Brill; Amira Klip; John H Brumell
Journal:  iScience       Date:  2022-09-24

Review 8.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

9.  Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis.

Authors:  Haibo Wang; Wenting Guo; Joy Mitra; Pavana M Hegde; Tijs Vandoorne; Bradley J Eckelmann; Sankar Mitra; Alan E Tomkinson; Ludo Van Den Bosch; Muralidhar L Hegde
Journal:  Nat Commun       Date:  2018-09-11       Impact factor: 14.919

Review 10.  Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases.

Authors:  Sang-Min Jang; Christophe E Redon; Bhushan L Thakur; Meriam K Bahta; Mirit I Aladjem
Journal:  Exp Mol Med       Date:  2020-10-02       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.